PROCALCITONIN Evaluation & Use In Victoria, BC
PROCALCITONIN Evaluation & Use In Victoria, BC PROCALCITONIN Evaluation & Use In Victoria, BC
ANALYZER SYSTEM METHOD MATRIX PCT ug/L Total Imprecision LLOQ ug/L BioMerieux VIDAS Chemiluminescence Monoclonal abs. Sandwich assay Vendor QC-1 15.28 2.91% BioMerieux VIDAS Vendor QC-2 1.76 3.56% 0.09 Roche Cobas e601 Human Pl.-1 0.07 6.94% Electro-Chemi- Roche Cobas e601 Luminescence Monoclonal abs. Human Pl.-2 4.86 1.35% Sandwich assay 0.05-0.07 Roche Cobas e601 Human Pl.-3 63.16 3.56% Table 1: Technology, precision and lower limit of quantitation of analyzer-systems
CONTENTS SIRS, SEPSIS, PCT HISTORY & PHYSIOLOGY ASSAYS & INITIAL EVALUATION RESULTS OF PCT VERSUS CRP IMPLEMENTATION OF TESTING SERVICE LESSONS OF THE FIRST 6 MONTHS OTHER USES
- Page 1 and 2: PROCALCITONIN Evaluation & Use In V
- Page 3 and 4: SIRS & SEPSIS: SIRS Systemic Infla
- Page 5 and 6: PHYSIOLOGY-1 PCT is the precursor
- Page 7 and 8: THYROID C-CELL
- Page 9 and 10: PHYSIOLOGY-2 Stimulated by bacteri
- Page 11 and 12: CONTENTS SIRS, SEPSIS, PCT HISTORY
- Page 13 and 14: INITIAL EVALUATION Objectives: Eva
- Page 15: 90 80 y = 0.8418x - 0.4055 R² = 0.
- Page 19 and 20: INITIAL PCT AND CRP RESULTS CULTURE
- Page 21 and 22: PCT v OTHER MKRS SOFA = Sequential
- Page 23 and 24: THE VALUE OF PCT Decision to treat
- Page 25 and 26: OTHER POSSIBLE VALUE Monitoring pat
- Page 27: IMPLEMENTATION 3 month evaluation
- Page 30 and 31: ACCEPTANCE OF TEST Generally good
- Page 32 and 33: FALSE RESULTS False negatives not
- Page 34 and 35: CONTENTS SIRS, SEPSIS, PCT HISTORY
- Page 36 and 37: PCT v HRS AFTER BIRTH Brahms’ dat
- Page 38 and 39: OTHER USES FOR PCT Prediction of r
- Page 40: KEY REFERENCES 1. Mirjam Christ-Cra
CONTENTS<br />
SIRS, SEPSIS, PCT HISTORY & PHYSIOLOGY<br />
ASSAYS & INITIAL EVALUATION<br />
RESULTS OF PCT VERSUS CRP<br />
IMPLEMENTATION OF TESTING SERVICE<br />
LESSONS OF THE FIRST 6 MONTHS<br />
OTHER USES
Change language